Overview
- 9 public-safe observations are available for this inspection.
- 6 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
12 Aug 2022
21 CFR 58.29(b)
Personnel: summary of training, job description
Cited by Corrine M Carter, Lynda L Lanning
12 Aug 2022
21 CFR 58.33(c)
Study director: unforeseen circumstances
Cited by Corrine M Carter, Lynda L Lanning
12 Aug 2022
21 CFR 58.35(b)(1)
QAU: maintain a master schedule
Cited by Corrine M Carter, Lynda L Lanning
12 Aug 2022
21 CFR 58.35(b)(5)
QAU: authorize deviations from protocols or SOPs
Cited by Corrine M Carter, Lynda L Lanning
Inspected site
LELabcorp Early Development Laboratories, Inc.Greenfield, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 58.81(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 58.107 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 58.29(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 58.33(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 58.35(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 58.35(b)(5) | Cited across public-safe Form 483 observations | 1x |
Source document
PDF
PDF available
Form 483 source document
The source document is available to authorized Atlas users.
Full 483 report
Get the verbatim text of all 9 observations
The source PDF, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere